Tapentadol is partially metabolized from the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medicines that increase or repress the action/expression of a number of of these enzymes, and with substrates of those enzymes (resulting from Levels of competition for that enzyme); some enzyme mediators/substrates have https://hermannw329cfe9.wikipublicist.com/user